Case Study: Veracuity improves adverse event reporting with DrugBank

Veracuity makes drugs safer with DrugBank data

Veracuity, a digital healthcare technology firm, sought to transform the disjointed system for reporting adverse drug events into a standardized, closed-loop process. Their challenge was the lack of accessible, highly structured, and reliable drug data needed to power their platform, as sourcing and organizing this data internally proved too arduous and inconsistent.

By integrating DrugBank's comprehensive datasets, including product concepts for detailed drug searches along with pharmacogenomics and drug interactions data, Veracuity found a solution. Using DrugBank's structured data eliminated the need for costly internal data sourcing, allowing Veracuity to focus on improving the feedback loop and standardization of adverse event reporting, ultimately creating a more effective and industry-wide safety system.

Veracuity

Sreeram Penna

Founder & Chief Medical Officer